Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith R McCrae

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
The New England Journal of Medicine|September 18, 2024
Pomalidomide for Epistaxis in Hereditary Hemorrhagic TelangiectasiaHanny Al-Samkari, Raj S Kasthuri, Vivek N Iyer, et al.
American Journal of Hematology|April 8, 2017
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopeniaDavid J Kuter, Barbara A Konkle, Taye H Hamza, et al.
Ebiomedicine|August 11, 2020
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversyMina K Chung, Sadashiva Karnik, Joshua Saef, et al.
The Journal of Experimental Medicine|August 26, 2017
CD55 regulates self-renewal and cisplatin resistance in endometrioid tumorsCaner Saygin, Andrew Wiechert, Vinay S Rao, et al.
Circulation|April 7, 2026
Olfactory Receptor Activation Reduces Platelet Reactivity and Arterial Thrombosis Through Actin Cytoskeleton RemodelingAnu Aggarwal, Vara Prasad V N Josyula, Nancy Wang, et al.
American Journal of Hematology|July 15, 2025
Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus ReportHanny Al-Samkari, Raj S Kasthuri, Hans-Jurgen Mager, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2026
Bradykinin Contributes to Vasogenic Edema in Murine Experimental Cerebral MalariaAlessandro de Sa Pinheiro, Douglas E Teixeira, Rodrigo P Silva-Aguiar, et al.
The New England Journal of Medicine|February 19, 2010
Dose of prophylactic platelet transfusions and prevention of hemorrhageSherrill J Slichter, Richard M Kaufman, Susan F Assmann, et al.
Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.
Blood Advances|December 15, 2023
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP RegistryMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
The New England Journal of Medicine|September 18, 2024
Pomalidomide for Epistaxis in Hereditary Hemorrhagic TelangiectasiaHanny Al-Samkari, Raj S Kasthuri, Vivek N Iyer, et al.
American Journal of Hematology|April 8, 2017
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopeniaDavid J Kuter, Barbara A Konkle, Taye H Hamza, et al.
Ebiomedicine|August 11, 2020
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversyMina K Chung, Sadashiva Karnik, Joshua Saef, et al.
The Journal of Experimental Medicine|August 26, 2017
CD55 regulates self-renewal and cisplatin resistance in endometrioid tumorsCaner Saygin, Andrew Wiechert, Vinay S Rao, et al.
Circulation|April 7, 2026
Olfactory Receptor Activation Reduces Platelet Reactivity and Arterial Thrombosis Through Actin Cytoskeleton RemodelingAnu Aggarwal, Vara Prasad V N Josyula, Nancy Wang, et al.
American Journal of Hematology|July 15, 2025
Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus ReportHanny Al-Samkari, Raj S Kasthuri, Hans-Jurgen Mager, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2026
Bradykinin Contributes to Vasogenic Edema in Murine Experimental Cerebral MalariaAlessandro de Sa Pinheiro, Douglas E Teixeira, Rodrigo P Silva-Aguiar, et al.
The New England Journal of Medicine|February 19, 2010
Dose of prophylactic platelet transfusions and prevention of hemorrhageSherrill J Slichter, Richard M Kaufman, Susan F Assmann, et al.
Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.
Blood Advances|December 15, 2023
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP RegistryMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Pageof 16